ReviewPharmacoEconomics2012
Economic evaluations of childhood influenza vaccination: a critical review.
Review in PharmacoEconomics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Epidemiological Assessment and Optimization of School-Based Influenza Vaccination - Shenzhen City, Guangdong Province, China, 2023-2024.China CDC weekly · 2025Article
- Influenza vaccination in Western Australian children: Exploring the health benefits and cost savings of increased vaccine coverage in children.Vaccine: X · 2023Article
- Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated Vaccines.Journal of the Canadian Association of Gastroenterology · 2021Review
- Inclusion of Safety-Related Issues in Economic Evaluations for Seasonal Influenza Vaccines: A Systematic Review.Vaccines · 2021Review
- Influenza vaccination in the COVID-19 era.Early human development · 2020Article
- The impact of influenza infection on young children, their family and the health care system.Influenza and other respiratory viruses · 2019Article
- WHO guide on the economic evaluation of influenza vaccination.Influenza and other respiratory viruses · 2018Review
- Economic Evaluation of Vaccination Programmes in Older Adults and the Elderly: Important Issues and Challenges.PharmacoEconomics · 2016Article
- Understanding the cost-effectiveness of influenza vaccination in children: methodological choices and seasonal variability.PharmacoEconomics · 2013Article
- Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies.Human vaccines & immunotherapeutics · 2013Review
- Economic benefits of inactivated influenza vaccines in the prevention of seasonal influenza in children.Human vaccines & immunotherapeutics · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The potential benefits of influenza vaccination programmes targeted at children have gained increasing attention in recent years. We conducted a literature search of economic evaluations of influenza vaccination in those aged ≤18 years. The search revealed 20 relevant articles, which were reviewed. The studies differed widely in terms of the costs and benefits that were included. The conclusions were generally favourable for vaccination, but often applied a wider perspective (i.e. including productivity losses) than the reference case for economic evaluations used in many countries. Several evaluations estimated outcomes from a single-year epidemiological study, which may limit their validity given the year-to-year variation in influenza transmissibility, virulence, vaccine match and prior immunity. Only one study used a dynamic transmission model able to fully incorporate the indirect herd protection to the wider community. The use of dynamic models offers great scope to capture the population-wide implications of seasonal vaccination efforts, particularly those targeted at children.
Indexed as
Identifiers
22788257What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.